Optimization of METTL3 Inhibitors for the Treatment of Solid Tumors and AML
Authors
- François Lenoir
- Guillaume Dutheuil (ORCID: https://orcid.org/0000-0002-8887-4823)
- Julien Korac
- Nicolas Probst (ORCID: https://orcid.org/0000-0003-1941-7132)
- Mohamed El Bousmaqui
- Nicolas Parmentier (ORCID: https://orcid.org/0000-0002-9114-3976)
- Killian Oukoloff
- Alexey Lapin
- Graeme L. Fraser (ORCID: https://orcid.org/0000-0001-9182-5929)
- Galina Nakhabina
- Catherine Sorlet
Institutions
- Bone Therapeutics (BE)
Publication Details
- Journal
- Journal of Medicinal Chemistry
- Published
- 2026-04-14
- DOI
- https://doi.org/10.1021/acs.jmedchem.6c00474
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Waalse Gewest